Low bone mineral density (BMD), which leaves bones weak and prone to fractures, was found to be prevalent among children…
Articles by Lindsey Shapiro, PhD
In the absence of treatment, the long-term progression of spinal muscular atrophy (SMA) types 2 and 3 is highly…
Adults with spinal muscular atrophy (SMA) showed alterations in body composition and metabolic disturbances, including changes in blood sugar…
Newborns diagnosed with spinal muscular atrophy (SMA) who were treated with Evrysdi (risdiplam) before the onset of symptoms…
An experimental high-dose regimen of spinal muscular atrophy (SMA) treatment Spinraza (nusinersen) is showing motor benefits for previously…
Babies born prematurely were diagnosed with spinal muscular atrophy (SMA) through newborn screening programs (NBS) in Germany and, in…
Brain abnormalities visible on MRI scans were seven times more likely in people with spinal muscular atrophy (SMA) than…
Untreated patients with spinal muscular atrophy (SMA) type 2 showed more changes in their ability to perform upper limb…
Treatment with Spinraza (nusinersen) generally stabilized or improved motor function for older patients with spinal muscular atrophy (SMA),…
Treatment with an investigational high-dose regimen of Spinraza (nusinersen) was well tolerated and significantly improved motor function in infants…